@article{0394422a26a446a382adaff2d34841da,
title = "Marketing of unproven stem cell-based interventions: A call to action",
abstract = "Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.",
keywords = "Journal Article, Review",
author = "Douglas Sipp and Timothy Caulfield and Jane Kaye and Jan Barfoot and Clare Blackburn and Sarah Chan and {De Luca}, Michele and Alastair Kent and Christopher McCabe and Megan Munsie and Margaret Sleeboom-Faulkner and Jeremy Sugarman and {van Zimmeren}, Esther and Amy Zarzeczny and Rasko, {John E J}",
note = "Copyright {\textcopyright} 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.",
year = "2017",
month = jul,
day = "5",
doi = "10.1126/scitranslmed.aag0426",
language = "English",
volume = "9",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "397",
}